Thema: US74587V1070
PBYI, US74587V1070
money-5338733_1920.jpg - Foto: THN
Puma Biotechnology stock gets higher 2026 Nerlynx outlook
Puma Biotechnology stock is in focus after a higher 2026 Nerlynx sales outlook. The company is also advancing its alisertib pipeline.
ad-hoc-news.de, heute 01:52 Uhr
PBYI, US74587V1070
Puma Biotechnology raises 2026 guidance. Q3 results test ...
Nerlynx revenue hit USD 95.5 million in the first half of 2026, up 3.5 percent year over year. November 5 results test Puma Biotechnology stock.
ad-hoc-news.de, 21.10.26 01:40 Uhr
PBYI, US74587V1070
Puma Biotechnology grants shares. TD Cowen targets Puma ...
Q2 revenue reached USD 56.50 million, up from USD 49.20 million. Puma Biotechnology stock has a USD 515.1 million market value on October 13, 2026.
ad-hoc-news.de, 14.10.26 05:35 Uhr
PBYI, US74587V1070
Puma Biotechnology stock fell 1.76 percent after award news ...
Puma Biotechnology granted 7,500 inducement shares on October 1, 2026. Its Q2 2026 EPS reached USD 0.19 against USD 0.04 consensus.
ad-hoc-news.de, 07.10.26 06:06 Uhr
Puma, Biotechnology
Puma Biotechnology Sets Date for Full-Year Financial Disclosure ...
